Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effect of CD47 Blockade on Vascular Inflammation

New England Journal of Medicine(2021)10.1056/nejmc2029834Source: DataRank Database

Effect of CD47 Blockade on Vascular Inflammation is a research paper published in New England Journal of Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 94 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access94 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.28)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Ryusuke Nakamoto ORCID,Brandon H Doan,Yoko Kojima ORCID,Irving L. Weissman ORCID,Ranjana H. Advani ORCID

Live enrichment

PubMed:33503349 PMC:PMC8175009 OpenAlex:https://openalex.org/W3122002269

National Institutes of Health

Grant: R35 HL144475

Deutsche Forschungsgemeinschaft

Grant: JA 2869/1-1:1

Deutsche Herzstiftung

Grant: S/09/19

American Heart Association

Grant: EIA34770065

NCI NIH HHS

Grant: R35 CA220434

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R35HL144475-03

Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis

Ludwig Cancer Foundation

Greathouse Family Foundation

FWCI

5.28

Citation Percentile

1.0%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.nejmgroup.org/legal/terms-of-use.htm

journalhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2029834?articleTools=true

BRONZEhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2029834?articleTools=true

publisherhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2029834?articleTools=true

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMc2029834

journalhttps://doi.org/10.1056/nejmc2029834

Fields of Study

Phagocytosis and Immune RegulationImmune cells in cancerAtherosclerosis and Cardiovascular DiseasesMedicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Immune Checkpoint InhibitorsAgedAged, 80 and overCarotid Artery DiseasesFemaleHumansInflammationMaleMiddle AgedRetrospective StudiesRadiopharmaceuticalsFluorodeoxyglucose F18Positron-Emission TomographyAtherosclerosisCD47 AntigenAntibodies, Monoclonal, Humanized

Keywords

InflammationBlockadeMedicineCardiologyInternal medicineReceptorAged, 80 and overCarotid Artery DiseasesMaleCD47 AntigenMiddle AgedAntibodies, Monoclonal, HumanizedAtherosclerosisFluorodeoxyglucose F18Positron-Emission TomographyHumansFemaleRadiopharmaceuticalsImmune Checkpoint InhibitorsAgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being